新闻
MDXG
--
0.00%
--
Next Capital Management LLC 购买金融精选行业 SPDR、医疗保健精选行业 SPDR、......
GuruFocus News · 11小时前
MIMEDX 将于 2021 年 12 月 7 日举办虚拟投资者日
MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or "the Company"), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that it will host a virtual Investor Day on Tuesday, December 7, 2021 beginning at 9:00 ...
GlobeNewswire · 5天前
与 MIMEDX 的净健康协议简化了复杂的保险福利验证
/PRNewswire/ -- , a leading provider of analytics and cloud-based software for specialty medical providers, announced today that it has added MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX") to the list of leading wound care providers that rely on Net Health® ...
PR Newswire - PRF · 6天前
MiMedx Group, Inc.(纳斯达克股票代码:MDXG)的股东所有权结构是这样的
A look at the shareholders of MiMedx Group, Inc. ( NASDAQ:MDXG ) can tell us which group is most powerful. Institutions...
Simply Wall St. · 09/30 15:40
MiMedx 员工帮助我揭露公司的欺诈行为:Marc Cohodes
Bloomberg · 09/29 11:30
MDXG:出乎意料的结果要求修订
By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT
Benzinga · 09/25 10:10
BELLUS Health、aTyr Pharma 领跑医疗保健赢家; Virpax Pharmaceuticals 和 RedHill Biopharma 是主要输家
Gainers: BELLUS Health (NASDAQ:BLU) +26%, aTyr Pharma (NASDAQ:LIFE) +22%, Jounce Therapeutics (NASDAQ:JNCE) +14%, NanoViricides (NYSE:NNVC) +12%, Matinas BioPharma (NYSE:MTNB) +12%. Losers: Virpax Pharmaceuticals (NASDAQ:VRPX) -37%, RedHill Biopharma (NASD...
Seekingalpha · 09/14 15:03
HC Wainwright 将 MiMedx 集团的目标价格从 20 美元上调至 8.50 美元,维持买入评级
MT Newswires · 09/14 10:31
HC Wainwright & Co. 维持对 MiMedx Group 的买入,将目标价下调至 8.5 美元
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains MiMedx Group (NASDAQ:MDXG) with a Buy and lowers the price target from $20 to $8.5.
Benzinga · 09/14 10:13
从昨天开始的 72 个最大的推动者
Gainers
Benzinga · 09/14 08:50
热门股票:票房兴奋; ITMR、TROX 因并购而上升; MDXG 试验失败; CVGW继续下滑
While COVID remains one of the key risks facing the broader markets, there have been signs that the post-pandemic reopening has persisted even in the face of the Delta variant.
Seekingalpha · 09/13 21:44
午后市场更新:道指上涨超过 100 点; Itamar Medical 股价飙升
Toward the end of trading Monday, the Dow traded up 0.38% to 34,739.18 while the NASDAQ fell 0.27% to 15,074.10. The S&P also fell, dropping 0.07% to 4,455.53.
Benzinga · 09/13 18:40
午盘市场更新:原油上涨 1%; MiMedx 集团股价暴跌
Midway through trading Monday, the Dow traded up 0.80% to 34,885.46 while the NASDAQ fell 0.10% to 15,100.02. The S&P also rose, gaining 0.23% to 4,468.75.
Benzinga · 09/13 16:17
板块更新:医疗保健股仍在午后下滑
MT Newswires · 09/13 15:47
Itamar Medical 和 aTyr Pharma 领跑医疗保健赢家; MiMedx、Silverback Therapeutics 是主要输家
Gainers: Itamar Medical (NASDAQ:ITMR) +45%, aTyr Pharma (NASDAQ:LIFE) +35%, iRhythm Technologies (NASDAQ:IRTC) +33%, REGENXBIO (NASDAQ:RGNX) +20%, Leap Therapeutics (NASDAQ:LPTX) +15%. Losers: MiMedx (NASDAQ:MDXG) -61%, Silverback Therapeutics (NASDAQ:SBTX...
Seekingalpha · 09/13 15:04
早盘市场更新:市场喜忧参半;英国终止 Valneva 的 COVID-19 疫苗合同
Following the market opening Monday, the Dow traded up 0.61% to 34,817.26 while the NASDAQ fell 0.40% to 15,055.69. The S&P also rose, gaining 0.05% to 4,460.84.
Benzinga · 09/13 14:29
为什么 MiMedx 股票今天跳水
MiMedx Group Inc (NASDAQ: MDXG) is trading significantly lower Monday after the company announced top-line results from two late-stage musculoskeletal clinical trials. 
Benzinga · 09/13 13:24
行业更新:医疗保健
MT Newswires · 09/13 12:55
Mimedx 股票在肌肉骨骼试验数据令人失望后暴跌
Benzinga · 09/13 12:38
微牛提供丰富的实时MDXG股票新闻,让你可以通过多个平台了解MDXG股票行情最新动态,这些免费的MIMEDX GROUP新闻可以帮助你做出明智投资。
MDXG 简况
MiMedx Group, Inc.(MiMedx)是来自人羊膜以及其他出生组织和人类皮肤与骨骼的再生生物材料产品和生物植入物的集成开发商、加工商和营销商。该公司通过再生生物材料业务部门运营业务,包括在伤口护理、手术、运动医学、眼科和牙科市场类别中从人羊膜和其他出生组织加工的再生生物材料产品和生物植入物的开发、加工和销售。其生物材料平台技术包括AmnioFix、EpiFix、OrthoFlo、Physio、AlloBurn和CollaFix。AmnioFix和EpiFix是源自捐赠的胎盘人羊膜处理组织技术。该公司使用其PURION工艺处理人羊膜,以产生植入物。MiMedx是羊膜组织的供应商,提供500,000多种同种异体移植物。